We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$133B
1-Year Est. Return
43.5%
This Fund
S&P 500
This Quarter
Est. Return
+26.39%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$133B
AUM Growth
+$15.7B
(+13%)
Cap. Flow
-$1.75B
Cap. Flow
% of AUM
-1.32%
Top 10 Holdings %
Top 10 Hldgs %
30.35%
Holding
4,370
New
224
Increased
1,883
Reduced
1,827
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$117M |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$117M |
| 3 |
SPCX
SpaceX
SPCX
|
+$100M |
| 4 |
P
Everpure Inc
P
|
+$67.3M |
| 5 |
Roku
ROKU
|
+$53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$212M |
| 2 |
Microsoft
MSFT
|
+$156M |
| 3 |
Amazon
AMZN
|
+$142M |
| 4 |
Honeywell
HON
|
+$119M |
| 5 |
NVIDIA
NVDA
|
+$94.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.1% |
| 2 | Financials | 11.93% |
| 3 | Industrials | 10.35% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Healthcare | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
James River Group Holdings
JRVR
$163M
| $202K | ﹤0.01% |
45,970
+300
| +0.7% | +$1.48K |
|
3002
American Resources Corp
AREC
$203M
| $200K | ﹤0.01% |
+93,056
| New | +$208K |
|
3003
EverCommerce
EVCM
$1.43B
| $200K | ﹤0.01% |
19,837
-399
| -2% | -$4.22K |
|
|
NAGE
3004
Niagen Bioscience
NAGE
$241M
| $199K | ﹤0.01% |
62,536
+1,960
| +3% | +$7.95K |
|
3005
Coherus Oncology
CHRS
$175M
| $199K | ﹤0.01% |
142,361
+17,260
| +14% | +$28.2K |
|
3006
Envela
ELA
$326M
| $199K | ﹤0.01% |
6,898
+1,788
| +35% | +$39.8K |
|
3007
Cadeler
CDLR
$2.27B
| $198K | ﹤0.01% |
9,051
+976
| +12% | +$24.8K |
|
|
ELMT
3008
The Elmet Group
ELMT
$598M
| $198K | ﹤0.01% |
+10,039
| New | +$172K |
|
3009
Western New England Bancorp
WNEB
$280M
| $198K | ﹤0.01% |
13,845
-309
| -2% | -$4.22K |
|
|
PXED
3010
Phoenix Education Partners
PXED
$932M
| $197K | ﹤0.01% |
6,001
+2,225
| +59% | +$66.5K |
|
3011
CPI Card Group
PMTS
$287M
| $197K | ﹤0.01% |
9,476
+1,419
| +18% | +$24.7K |
|
3012
Greenwich LifeSciences
GLSI
$267M
| $197K | ﹤0.01% |
8,387
+341
| +4% | +$8.3K |
|
3013
Vista Gold
VGZ
$401M
| $197K | ﹤0.01% |
+102,901
| New | +$224K |
|
|
FBLA
3014
FB Bancorp
FBLA
$239M
| $195K | ﹤0.01% |
12,966
-509
| -4% | -$7.21K |
|
3015
inTEST
INTT
$148M
| $195K | ﹤0.01% |
+10,737
| New | +$182K |
|
|
PAL
3016
Proficient Auto Logistics
PAL
$103M
| $194K | ﹤0.01% |
28,480
+323
| +1% | +$2.16K |
|
3017
Foghorn Therapeutics
FHTX
$208M
| $193K | ﹤0.01% |
39,582
+77
| +0.2% | +$342 |
|
3018
LifeMD
LFMD
$143M
| $193K | ﹤0.01% |
46,693
+1,989
| +4% | +$8.78K |
|
|
EVMN
3019
Evommune Inc
EVMN
$308M
| $193K | ﹤0.01% |
14,495
+2,674
| +23% | +$62.1K |
|
3020
Corbus Pharmaceuticals
CRBP
$138M
| $192K | ﹤0.01% |
20,463
+19,981
| +4,145% | +$189K |
|
3021
Information Services Group
III
$255M
| $192K | ﹤0.01% |
46,662
+3,151
| +7% | +$13.2K |
|
3022
Inogen
INGN
$142M
| $191K | ﹤0.01% |
29,606
-1,299
| -4% | -$8.6K |
|
3023
BCB Bancorp
BCBP
$158M
| $191K | ﹤0.01% |
17,772
-774
| -4% | -$7.9K |
|
|
SPRB
3024
Spruce Biosciences
SPRB
$140M
| $190K | ﹤0.01% |
+3,519
| New | +$197K |
|
3025
Thomson Reuters
TRI
$42.9B
| $190K | ﹤0.01% |
2,326
-723
| -24% | -$63.2K |
|
Similar funds
RhumbLine Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, RhumbLine Advisers held 4,370 positions worth $133B, up 13% from $117B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
RhumbLine Advisers's Q2 2026 filing shows 224 new, 1,883 increased, 1,827 reduced and 182 closed positions. Its largest new stake was Honeywell Aerospace: 529,091 shares worth $117M. The largest sale was Apple, an estimated $212M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- RhumbLine Advisers's largest Q2 2026 buy was Honeywell Aerospace: 529,091 shares worth $117M.
- RhumbLine Advisers added most to Marvell Technology in Q2 2026, an estimated $117M increase.
- RhumbLine Advisers's biggest Q2 2026 reduction was Apple, cutting an estimated $212M.
- RhumbLine Advisers fully exited Coterra Energy in Q2 2026, selling an estimated $53.5M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $133B portfolio in Q2 2026.
- RhumbLine Advisers opened 224 new positions and closed 182 in Q2 2026.
- RhumbLine Advisers's portfolio value rose 13% quarter-over-quarter to $133B.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.